RBR-2f8mtn已完成未知
Cannabis oil in Fibromyalgic people
Escola de Saúde Pública de Florianópolis0 个研究点开始时间: 2020年3月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 —（—）
入选标准
- •Fibromyalgia diagnosis (ACR 2010 criteria); age over 18 years; ability to sign the informed consent form; presence of moderate to severe symptoms despite therapies in use; at least one medical or nursing consultation at Health Center on the last year.
排除标准
- •Decompensated organic comorbidities and/or risk psychiatric conditions (schizophrenia, psychosis, severe personality disorder, current suicidal ideation); other well defined cause of chronic pain; current pregnancy/lactation; moderate or severe cognitive impairment; history of cannabinoids sensitivity.
研究者
相似试验
进行中（未招募）
1 期
Medical Cannabis for FibromyalgiaMedDRA version: 20.0Level: LLTClassification code 10016631Term: Fibromyalgia syndromeSystem Organ Class: 100000004859FibromyalgiaEUCTR2019-002394-59-DKThe Parker Institute, Bispebjerg and Frederiksberg Hospital200
Unknown
2 期
CBD (Cannabidiol)/THC (Tetrahydrocannabinol) Solution as a Pharmacological Strategy for Patients With Fibromyalgia (FibroCann)FibromyalgiaNCT05283161FG Brasil LTDA40
进行中（未招募）
不适用
TO FIND OUT THE EFFECT OF VARIOUS ALTERNATIVE TREATMENTS IN WOMEN WITH MUSCULOSKELETAL PAIN AND STIFFNESS AND TENDERNESS AT SPECIFIC BODY SITES.CTRI/2022/04/041601DrPriyanka Sethi
已完成
3 期
Cannabidiol for Fibromyalgia (The CANNFIB Trial)FibromyalgiaNCT04729179Marius Henriksen200
已完成
不适用
Effects of acupuncture on patients with fibromyalgiaISRCTN60217348Carlos III Institute of Health (Instituto de Salud Carlos III) (Spain)150